Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prostate Cancer
100%
Chemoresistance
100%
Epithelial-mesenchymal Transition
100%
Radioresistance
100%
Androgen Deprivation Therapy Resistance
100%
Transforming Growth Factor-β
50%
Tumor Microenvironment
50%
Anoikis
50%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
50%
Chemotherapy
25%
Effective Treatment
25%
Apoptosis
25%
Cancer Cells
25%
Recurrent Prostate Cancer
25%
Signaling Pathway
25%
Existing Data
25%
Glands
25%
Therapeutic Approaches
25%
Extracellular Matrix
25%
Stem Cells
25%
Mesenchymal Cells
25%
Resistance to Chemotherapy
25%
Chemotherapy Resistance
25%
Life-threatening
25%
Metastatic Potential
25%
Epithelium
25%
Ment
25%
Apoptosis Inhibition
25%
Therapeutic Response
25%
Prostate Tumor
25%
Redifferentiation
25%
Growth Factor Signaling
25%
Androgen Receptor
25%
Novel Therapeutic Targets
25%
E-cadherin
25%
Resistance Development
25%
Clinical Care
25%
Migratory Phenotype
25%
Adherent Junction
25%
Androgen Signaling
25%
Invasive Phenotype
25%
Androgen Deprivation Therapy
25%
Invasive Ability
25%
Cancer Evolution
25%
Therapeutic Interventions
25%
Evade
25%
Potential Effectiveness
25%
Cellular Dedifferentiation
25%
Biochemistry, Genetics and Molecular Biology
Drug Resistance
100%
Mesenchymal-Epithelial Transition
100%
Radiosensitivity
100%
Signal Transduction
50%
Androgen Receptor
50%
Programmed Cell Death
50%
Cancer Growth Factor
50%
Anoikis
50%
Stem Cell
25%
Cancer Cell
25%
Downregulation
25%
Gene Linkage
25%
Diazepam
25%
Cadherin
25%
Cell Dedifferentiation
25%
Growth Factor Signaling
25%
Chemical Engineering
Malignant Neoplasm
100%
Cancer
100%
Tumor Microenvironment
33%